Template:Septic Bursitis Antibiotics: Difference between revisions

(Created page with "*Cover Staphylococcus aureus Streptococcus (including MRSA) '''Outpatient Options:''' *Clindamycin 300 mg PO three times daily x 10 days *TMP/SMX 2 DS tabs...")
 
 
(3 intermediate revisions by 3 users not shown)
Line 1: Line 1:
*Cover [[Staphylococcus aureus]] [[Streptococcus]] (including [[MRSA]])
''Cover [[Staphylococcus aureus]] (80-90%) and [[Streptococcus]]
'''Outpatient Options:'''
 
*[[Clindamycin]] 300 mg PO three times daily x 10 days
====Outpatient Options====
*[[TMP/SMX]] 2 DS tabs PO two times daily x 10 days
*[[Clindamycin]] 300 mg PO three times daily x 14 days '''OR'''
*[[Dicloxacillin]] 500mg q6hr x10 days
*[[TMP/SMX]] 2 DS tabs PO two times daily x 14 days '''OR'''
'''Inpatient Options'''
*[[Dicloxacillin]] 500mg PO q6hr x10 days
*[[Vancomycin]] 15-20 mg/kg IV BID
''Treatment followup with primary physician is important since the regimen may need extension to 3 weeks.''
*[[Clindamycin]] 600 mg IV three times daily
 
====Inpatient Options====
*[[Vancomycin]] 25-30 mg/kg IV loading then 15-20 mg/kg IV '''OR'''
*[[Clindamycin]] 600 mg (10/mg/kg) IV three times daily
*[[Linezolid]] 600 mg IV BID (10mg/kg Q8hrs for pediatrics)

Latest revision as of 16:01, 18 January 2019

Cover Staphylococcus aureus (80-90%) and Streptococcus

Outpatient Options

Treatment followup with primary physician is important since the regimen may need extension to 3 weeks.

Inpatient Options

  • Vancomycin 25-30 mg/kg IV loading then 15-20 mg/kg IV OR
  • Clindamycin 600 mg (10/mg/kg) IV three times daily
  • Linezolid 600 mg IV BID (10mg/kg Q8hrs for pediatrics)